Paushak

By Manoj Kumar

NEW DELHI, March 18 (Reuters) - India on Tuesday opened an anti-dumping investigation into ethyl chloroformate imports from China after a domestic producer alleged the chemical used in pharmaceutical and agrochemical manufacturing was being sold at unfairly low prices.

The Directorate General of Trade Remedies (DGTR), under the federal trade ministry, said it initiated the probe following an application by Paushak PAUS.NS that alleged that imports from China had caused "material injury" to domestic producers.

The Chinese embassy in New Delhi did not immediately respond to a request for comment.

In December, India imposed a three-year import tariff of 11% to 13% on some steel imports, in an effort to curb cheap Chinese products.

Ethyl chloroformate is an organic chemical intermediate widely used in pharmaceutical and agrochemical manufacturing.

The probe could lead to import duties, higher costs for drugmakers and agrochemical firms while shielding local producers if dumping is confirmed, trade analysts said.

In a statement, the DGTR said it would examine whether the product was being dumped on the Indian market and whether anti-dumping duties were warranted to offset the alleged injury to domestic producers.

In its filing, Paushak said it is India's sole domestic producer of ethyl chloroformate and it is responsible for the country's entire output. It alleged that rising imports from China had led to price suppression and weakened profitability.

The DGTR said its preliminary assessment indicated the dumping margin appeared to be above the de minimis level, suggesting significant price undercutting by Chinese exporters.

The investigation will cover the period from October 2024 to September 2025, the DGTR said, and will assess evidence from exporters, importers and other interested parties before deciding whether to recommend duties to the government.

In a separate case, the DGTR also initiated an anti-dumping investigation into imports of hexamine - another intermediate used by the chemical and pharmaceutical industries - originating in or exported from China, Russia and the United Arab Emirates.

(Reporting by Manoj Kumar; Editing by Thomas Derpinghaus)

(([email protected]; +919810286200; Twitter:@manojgulnar;))

Jan 21 (Reuters) - Paushak Ltd PAUS.NS:

• COMPANY INITIATES COMMISSIONING OF NEW MULTI-PURPOSE PLANT

• INVESTMENT ABOUT 1.75 BILLION RUPEES

Source text: ID:nNSEc6l8cN

Further company coverage: PAUS.NS

(([email protected];))

Aug 11 (Reuters) - Paushak Ltd PAUS.BO:

• ISSUE BONUS SHARES IN 3:1 RATIO

Source text: ID:nBSE6j1f5

Further company coverage: PAUS.BO

(([email protected];;))

April 2 (Reuters) - Paushak Ltd PAUS.BO:

• PAUSHAK - ABHIJIT JOSHI RESIGNS AS CEO

Source text: ID:nBSE4YKy1t

Further company coverage: PAUS.BO

(([email protected];;))

Dec 10 (Reuters) - Paushak Ltd PAUS.BO:

• GETS ORDER WORTH 5.9 MILLION RUPEES FROM PAUSHAK

Source text: ID:nNSEyc3HQ

Further company coverage: PAUS.BO

(([email protected];))

Dec 6 (Reuters) - Paushak Ltd PAUS.BO:

• PAUSHAK LTD - ANNUAL MAINTENANCE OF PLANTS AND UTILITIES HAS BEEN COMPLETED

• PAUSHAK LTD - PHASE WISE MANUFACTURING OPERATIONS RESUMED WITH EFFECT FROM DEC 6

Source text: ID:nBSE7Vxg29

Further company coverage: PAUS.BO

(([email protected];))

** Specialty chemicals maker Paushak PAUS.BO falls ~4% to 5,290 rupees

** Co will shut its manufacturing facilities for annual maintenance in phases between Nov. 26 and Dec. 6

** PAUS did not disclose the quantified hit to production due to the closure

** YTD, stock down ~13%

(Reporting by Hritam Mukherjee in Bengaluru)

(([email protected];))

Nov 25 (Reuters) - Paushak Ltd PAUS.BO:

• PAUSHAK - TO SHUTDOWN MANUFACTURING FACILITIES FROM NOV 26 TO DEC 6 FOR MAINTENANCE

Source text: ID:nBSE43ncXZ

Further company coverage: PAUS.BO

(([email protected];))

Oct 2 (Reuters) - Paushak Ltd PAUS.BO:

• PROPOSING TO UNDERTAKE SHUTDOWN OF ITS VARIOUS MANUFACTURING FACILITIES IN A PHASED MANNER

• SHUTDOWN FROM 2ND OCTOBER TO 27TH OCTOBER

Source text for Eikon: ID:nBSE5ZxpV3

Further company coverage: PAUS.BO

(([email protected];))

May 4 (Reuters) - Paushak Ltd PAUS.BO:

• MARCH-QUARTER PAT 143.5 MILLION RUPEES VERSUS 132.2 MILLION RUPEES

• MARCH-QUARTER REVENUE FROM OPERATIONS 564.6 MILLION RUPEES VERSUS 526.2 MILLION RUPEES

• DIVIDEND 17.50 RUPEES PER SHR

• ABHIJIT JOSHI REAPPOINTED CEO

Source text for Eikon: ID:nBSE62FjGw

Further company coverage: PAUS.BO

(([email protected];))